PARP1 and cancer: PARP-1 has been investigated as a therapeutic oncology target [4], it induces synthetic lethality efficiently in cancers that are deficient in certain DNA repair mechanisms (BRCA1/2 and ATM) and dependent on upregulated PARP-1 activity for survival [5].